Vascular involvement in systemic sclerosis (scleroderma)

@inproceedings{Pattanaik2011VascularII,
  title={Vascular involvement in systemic sclerosis (scleroderma)},
  author={Debendra Pattanaik and Monica L. Brown and Arnold E. Postlethwaite},
  booktitle={Journal of inflammation research},
  year={2011}
}
Systemic sclerosis (SSc) is an acquired multiorgan connective tissue disease with variable mortality and morbidity dictated by clinical subset type. The etiology of the basic disease and pathogenesis of the systemic autoimmunity, fibrosis, and fibroproliferative vasculopathy are unknown and debated. In this review, the spectrum of vascular abnormalities and the options currently available to treat the vascular manifestations of SSc are discussed. Also discussed is how the hallmark pathologies… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 28 CITATIONS

The role of platelets in the pathogenesis of systemic sclerosis

  • Front. Immun.
  • 2012
VIEW 12 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 242 REFERENCES

Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis. Drugs

S. Dhillon
  • 2009
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis

F Del Galdo, F Sotgia, CJ de Almeida
  • Arthritis Rheum
  • 2008
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Raynaud's phenomenon: pathogenesis and management.

  • Journal of the American Academy of Dermatology
  • 2008
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…